Skip to main content
Clinical Trials/NCT00504621
NCT00504621
Completed
N/A

The Influence of Personality on Quality of Life, Fatigue, Prognosis, and Health Care Consumption in Pulmonary Fibrosis and Sarcoidosis

Maastricht University Medical Center0 sites450 target enrollmentAugust 2007

Overview

Phase
N/A
Intervention
Not specified
Conditions
Sarcoidosis
Sponsor
Maastricht University Medical Center
Enrollment
450
Primary Endpoint
The role of personality factors as predictors in sarcoidosis and pulmonary fibrosis.
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

A number of studies have shown that the quality of life of two common interstitial lung diseases (ild), sarcoidosis and pulmonary fibrosis patients, is impaired and that fatigue is a substantial problem for those patients. Furthermore, breathlessness is an additional major problem in pulmonary fibrosis. In the field of cardiovascular disease and breast cancer, personality factors have shown to play a role in patient's morbidity, mortality, quality of life, fatigue, depressive symptoms, and one study showed a predictive role of personality factors in health care consumption. No studies examining personality factors have been performed in sarcoidosis or pulmonary fibrosis. Therefore, the aim of the present study is to examine the role of personality factors as predictors of fatigue, quality of life, prognosis, and health care consumption in sarcoidosis and pulmonary fibrosis. In this study a number of possible moderators, such as social support, will also be examined, aiming to get a full picture of the relationship between the various factors examined. Known and new sarcoidosis and pulmonary fibrosis patients (inclusion period 1 year) of ild care team of the outpatient clinic of the department of Respiratory Medicine of the University Hospital Maastricht will be asked to participate through completing questionnaires at baseline and every six months for 18 months, and allowing the researchers access to their medical records for the purpose of this study.

Registry
clinicaltrials.gov
Start Date
August 2007
End Date
January 2009
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients have to be diagnosed with sarcoidosis based on consistent clinical features and BAL fluid analysis results, according to the WASOG guidelines.
  • The diagnosis IPF will be made based on the ATS guidelines

Exclusion Criteria

  • Poor expression in the Dutch language
  • Relevant co morbidity such as a malignancy, dementia, and a history of psychiatric illness

Outcomes

Primary Outcomes

The role of personality factors as predictors in sarcoidosis and pulmonary fibrosis.

Time Frame: 18 months

The role of personality factors as predictors of fatigue, quality of life, prognosis, and health care consumption in sarcoidosis and pulmonary fibrosis.

Similar Trials